RPT-Mylan independence from Teva's embrace comes with a price
July 28, 2015 at 07:00 AM EDT
July 27 (Reuters) - Generic drugmaker Mylan NV won a reprieve on Monday from its unwanted suitor, Teva Pharmaceutical Industries, but now faces an uphill battle to make its own acquisition as its biggest rival just got bigger.